Protein Kinase C enzyme “PKC”
Focused on one goal: Developing Novel Therapeutics to tame Cancer
Message: Tough Day
| Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | # or value acquired or disposed of | Unit Price |
| Aug 01/09 | Jul 27/09 | Letellier, Robert | Direct Ownership | Common Shares | 10 - Disposition in the public market | -12,500 | $0.310 |
| Aug 01/09 | Jul 27/09 | Letellier, Robert | Direct Ownership | Common Shares | 10 - Disposition in the public market | -56,000 | $0.300 |
| Aug 01/09 | Jul 27/09 | Letellier, Robert | Direct Ownership | Common Shares | 10 - Disposition in the public market | -106,500 | $0.300 |
| Jul 29/09 | Jul 27/09 | Bryden, Roderick M. | Control or Direction | Common Shares | 10 - Disposition in the public market | -100,000 | $0.300 |
| Jul 29/09 | Jul 27/09 | Bryden, Roderick M. | Control or Direction | Common Shares | 10 - Disposition in the public market | -100,000 | $0.324 |
| Jul 29/09 | Jul 27/09 | Bryden, Roderick M. | Control or Direction | Common Shares | 10 - Disposition in the public market | -100,000 | $0.330 |
| Jul 29/09 | Jul 27/09 | Bryden, Roderick M. | Control or Direction | Common Shares | 10 - Disposition in the public market | -100,000 | $0.340 |
| Jul 29/09 | Jul 27/09 | Bryden, Roderick M. | Control or Direction | Common Shares | 10 - Disposition in the public market | -100,000 | $0.333 |
Loading...
Loading...
New Message
Please
login
to post a reply